U.S. Provisional 64/029,363 · Filed April 4, 2026

WoofWizeX-FRS

Companion-animal sensing research and validation platform

WoofWizeX-FRS explores privacy-aware, contactless sensing workflows for companion-animal monitoring using ambient-signal observations and controlled data provenance. The current public status is research and validation—not a clinical, diagnostic, or field-accuracy claim.

Implemented foundation

What exists now

  • • Acquisition and modality-neutral observation infrastructure.
  • • Local APIs and controlled data-ingestion paths.
  • • Provenance-gated analytics and evidence handling.
  • • Validation tooling and explicit identity / health capture campaign structure.
  • • A filed provisional IP lane covering the WoofWizeX-FRS family.
Required before stronger claims

What still must be validated

  • • Physical capture fixtures with retained device, firmware, calibration, and capture provenance.
  • • Commercially authorized canine dataset lineage.
  • • Subject-, day-, and environment-disjoint evaluation.
  • • Field accuracy and false-positive characterization.
  • • Prospective veterinary validation before diagnostic or medical-alert claims.
Commercialization role

A funded validation lane, not an unsupported finished-product claim.

WoofWizeX-FRS is currently best suited to research partnerships, design-partner discussions, dataset and field-validation work, and milestone-matched non-dilutive R&D support. MT Tech does not publish a product accuracy number, veterinary outcome claim, or diagnostic claim until the required external evidence exists.

Research partners

Animal-health, veterinary, welfare, and sensing researchers able to support controlled validation.

Design partners

Organizations willing to define a measurable monitoring problem and participate in evidence-producing trials.

R&D funding

Programs that fund defined technical validation milestones rather than unsupported market-readiness claims.

Discuss a validation partnership

Qualified research, veterinary, sensing, funding, and commercialization partners can request a public-safe discussion or protected technical review.